These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21343749)

  • 1. Pharmacogenomics and management of cardiovascular disease.
    Howe LA
    Nursing; 2011; 41 Suppl():1-7. PubMed ID: 21343749
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacogenetics--new perspectives in the treatment of cardiovascular diseases].
    Dzida G
    Kardiol Pol; 2004 Mar; 60(3):304-8. PubMed ID: 15156230
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cardiovascular pharmacogenomics].
    Ahlehoff O; Hansen PR
    Ugeskr Laeger; 2009 Apr; 171(17):1405-7. PubMed ID: 19413939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymes and pharmacogenetics of cardiovascular drugs.
    Siest G; Jeannesson E; Visvikis-Siest S
    Clin Chim Acta; 2007 May; 381(1):26-31. PubMed ID: 17362901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the genetic causes of inter-patient variability. Clinical relevance with focus on cardiovascular drugs.
    Ginghină C; Stănescu R; Coman IM; Bărbari L; Popescu BA
    Rom J Intern Med; 2007; 45(4):313-9. PubMed ID: 18767405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacogenomics for cardiovascular drugs].
    Komamura K
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():465-70. PubMed ID: 16897881
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacogenomics and cardiology: improving treatment with existing drugs.
    Sorrentino MJ; O'Donnell PH
    Pharmacogenomics; 2015; 16(11):1223-6. PubMed ID: 26369612
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical Implementation of Cardiovascular Pharmacogenomics.
    Pereira NL; Stewart AK
    Mayo Clin Proc; 2015 Jun; 90(6):701-4. PubMed ID: 26046404
    [No Abstract]   [Full Text] [Related]  

  • 9. Updates on cytochrome P450-mediated cardiovascular drug interactions.
    Cheng JW; Frishman WH; Aronow WS
    Am J Ther; 2009; 16(2):155-63. PubMed ID: 19114873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics and management of cardiovascular disease.
    Howe LA
    Nurse Pract; 2009 Aug; 34(8):28-35; quiz 36. PubMed ID: 19638892
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cardiovascular pharmacology].
    Ravens U; Erdmann E
    Dtsch Med Wochenschr; 2004 Apr; 129(15):799. PubMed ID: 15054684
    [No Abstract]   [Full Text] [Related]  

  • 12. Ethnic differences in cardiovascular drug response: potential contribution of pharmacogenetics.
    Johnson JA
    Circulation; 2008 Sep; 118(13):1383-93. PubMed ID: 18809808
    [No Abstract]   [Full Text] [Related]  

  • 13. Avoiding psychotropic drug interactions in the cardiovascular patient.
    DeVane CL; Markowitz JS
    Bull Menninger Clin; 2000; 64(1):49-59. PubMed ID: 10695159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics in cardiovascular clinical trials.
    Shah R; Darne B; Atar D; Abadie E; Adams KF; Zannad F;
    Fundam Clin Pharmacol; 2004 Dec; 18(6):705-8. PubMed ID: 15548243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacogenomics of cardiovascular pharmacology].
    Tanaka T; Oka T; Iwao H
    Nihon Yakurigaku Zasshi; 2006 Sep; 128(3):130-2. PubMed ID: 16971774
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cardiovascular diseases: present and future based on molecular biology].
    Oseguera Moguel J
    Rev Invest Clin; 2003; 55(2):155-60. PubMed ID: 12827919
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacogenomics to Revive Drug Development in Cardiovascular Disease.
    Dubé MP; de Denus S; Tardif JC
    Cardiovasc Drugs Ther; 2016 Feb; 30(1):59-64. PubMed ID: 26768480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethnic, racial, and sex-specific factors are important in cardiovascular pharmacotherapeutics.
    Caracciolo VJ; Shaefer BM; Charney P
    Arch Intern Med; 2002 Nov; 162(21):2494; author reply 2494-5. PubMed ID: 12437417
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers.
    Siest G; Marteau JB; Maumus S; Berrahmoune H; Jeannesson E; Samara A; Batt AM; Visvikis-Siest S
    Eur J Pharmacol; 2005 Dec; 527(1-3):1-22. PubMed ID: 16316654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of genetic polymorphisms of cytochrome P450 in drug metabolism used in the treatment of cardiovascular diseases].
    Wojtczak A; Skretkowicz J
    Kardiol Pol; 2009 Sep; 67(9):1011-4. PubMed ID: 19838960
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.